Registry of Pancreatic Exocrine Insufficiency.

Hospital Clinico Universitario de Santiago

Status: Enrolling

Conditions: Exocrine Pancreatic Insufficiency

Treatments: Drug: Pancreatic Enzyme

Study type: Observational

Funder types: Other

Identifiers

NCT05450627

PEI-01-2021

Details and patient eligibility

About

A prospective, cross-sectional, observational study has been designed with the aim of the study is to evaluate the diagnosis and management of patients with pancreatic exocrine insufficiency secondary to different pancreatic diseases and conditions in clinical practice.

A registry has been develop to include patients older than 18 years diagnosed with pancreatic exocrine insufficiency, sho are willing to participate in the study and sign the informed consent.

Registry includes demographics, toxic habits,pharmacological therapies, underlying disease that causes pancreatic exocrine insufficiency.

Enrollment: 1,000 estimated patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patients older than 18 years diagnosed with PEI secondary to pancreatic diseases, pancreatectomy, or gastrectomy.
• Willingness to participate in the study.

Exclusion criteria

• Patients with pancreatic diseases without PEI.
• Pregnancy
• Known allergy to oral pancreatic enzymes
• Any condition avoiding adequate clinical management of PEI.
• Patients who are not willing to participate in the study.

Trial design

1,000 participants in 1 patient group

Case

Description:

Adult patients diagnosed with pancreatic exocrine insufficiency of any etiology

Treatment:

Drug: Pancreatic Enzyme